High levels of C-reactive protein do not increase the risk of ischemic vascular disease

2009 ◽  
Vol 5 (2) ◽  
pp. 64-64
Keyword(s):  
Vascular Disease ◽  
C Reactive Protein ◽  
Reactive Protein

scholarly journals Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease

2020 ◽  
Vol 5 (10) ◽  
pp. 1136 ◽  
Author(s):  
Rishi Puri ◽  
Steven E. Nissen ◽  
Benoit J. Arsenault ◽  
Julie St John ◽  
Jeffrey S. Riesmeyer ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
High Risk ◽  
Vascular Disease ◽  
C Reactive Protein ◽  
Lipoprotein A ◽  
Reactive Protein

C-reactive protein and interleukin-6 in vascular disease

2003 ◽  
Vol 21 (10) ◽  
pp. 1787-1803 ◽  
Author(s):  
Marcello Rattazzi ◽  
Massimo Puato ◽  
Elisabetta Faggin ◽  
Barbara Bertipaglia ◽  
Alberto Zambon ◽  
...  
Keyword(s):  
Vascular Disease ◽  
Interleukin 6 ◽  
C Reactive Protein ◽  
Reactive Protein

Abstract 067: Predictors of High-sensitivity C-reactive Protein Elevation Among Patients With Myocardial Infarction: Insights From VIRGO and TRIUMPH

2017 ◽  
Vol 10 (suppl_3) ◽  
Author(s):  
Mohammed Qintar ◽  
Puza P Sharma ◽  
Yuanyuan Tang ◽  
Philip Jones ◽  
Yashashwi Pokharel ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
High Sensitivity ◽  
Peripheral Vascular ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
History Of ◽  
Multivariable Regression ◽  
Hs Crp

Background: Elevated hs-CRP is associated with worse cardiovascular outcomes in patients with acute myocardial infarction (AMI), but little is known about predictors of elevated hs-CRP after AMI. Methods: TRIUMPH and VIRGO are prospective AMI registries that assessed hs-CRP levels 30 days after AMI. TRIUMPH assessed hs-CRP levels at 6 months. Multivariable regression analysis was conducted to examine predictors of elevated hs-CRP [≥2.0 mg/L] at 30 days and at 6 months after an AMI (TRIUMPH only). Results: Of 3410 patients in both registries, 58.6% had elevated hs-CRP 30 days post AMI. Patients with elevated hs-CRP were more likely to be female, black, obese, smokers, to have had higher LDL-C at the time of their AMI, with more peripheral vascular disease and history of heart failure, and were less likely to have had a prior PCI (Table). In TRIUMPH, baseline hs-CRP ≥2 mg/L (n=1301) was significantly associated with elevated hs-CRP at 6 months (p<0.001). Patients with elevated hs-CRP at 6 months (n=407) were more likely to be black, obese, smokers, have peripheral vascular disease and have higher baseline hs-CRP. Conclusions: hs-CRP remains elevated in a large proportion of patients following AMI. We identified several predictors of elevated hs-CRP at 1 and 6 months post AMI. Further studies are needed to validate the findings and understand the utility of routine screening of hs-CRP in post AMI patients.

Sign in / Sign up

Export Citation Format

Share Document